Divergent co-transmitter actions underlie motor pattern activation by a modulatory projection neuron.
Co-transmission is a common means of neuronal communication, but its consequences for neuronal signaling within a defined neuronal circuit remain unknown in most systems. We are addressing this issue in the crab stomatogastric nervous system by characterizing how the identified modulatory commissural neuron (MCN)1 uses its co-transmitters to activate the gastric mill (chewing) rhythm in the stomatogastric ganglion (STG). MCN1 contains gamma-aminobutyric acid (GABA) plus the peptides proctolin and Cancer borealis tachykinin-related peptide Ia (CabTRP Ia), which it co-releases during the retractor phase of the gastric mill rhythm to influence both retractor and protractor neurons. By focally applying each MCN1 co-transmitter and pharmacologically manipulating each co-transmitter action during MCN1 stimulation, we found that MCN1 has divergent co-transmitter actions on the gastric mill central pattern generator (CPG), which includes the neurons lateral gastric (LG) and interneuron 1 (Int1), plus the STG terminals of MCN1 (MCN1(STG)). MCN1 used only CabTRP Ia to influence LG, while it used only GABA to influence Int1 and the contralateral MCN1(STG). These MCN1 actions caused a slow excitation of LG, a fast excitation of Int1 and a fast inhibition of MCN1(STG). MCN1-released proctolin had no direct influence on the gastric mill CPG, although it likely indirectly regulates this CPG via its influence on the pyloric rhythm. MCN1 appeared to have no ionotropic actions on the gastric mill follower motor neurons, but it did use proctolin and/or CabTRP Ia to excite them. Thus, a modulatory projection neuron can elicit rhythmic motor activity by using distinct co-transmitters, with different time courses of action, to simultaneously influence different CPG neurons.
Stein
Wolfgang
W
Department of Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
DeLong
Nicholas D
ND
Wood
Debra E
DE
Nusbaum
Michael P
MP
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D003386:Brachyura; D002118:Calcium / Q000378:metabolism; D004064:Digestive System / Q000294:innervation; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D017952:Ganglia, Invertebrate / Q000166:cytology; D066298:In Vitro Techniques; D008297:Male; D009046:Motor Neurons / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D009415:Nerve Net / Q000187:drug effects / Q000502:physiology*; D009479:Neuropeptides / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000494:pharmacology / Q000502:physiology*; D009842:Oligopeptides / Q000494:pharmacology; D010507:Periodicity; D010812:Physical Stimulation / Q000379:methods; D015320:Tachykinins / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D009479:Neuropeptides; D018377:Neurotransmitter Agents; D009842:Oligopeptides; D015320:Tachykinins; D005680:gamma-Aminobutyric Acid; C011536:proctolin; D002118:Calcium